Skip to content

APOTHEEK KOUTER: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK KOUTER

BE 0476.627.118
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€169,553
2024 · €181,867-€12,314
Equity
€288,374
2024 · €344,274-€55,900
Cash
€354,760
2024 · €116,732+€238,028
Balance sheet total
€881,569
2024 · €858,578+€22,991

Largest movements

2024 to 2025
Assets
  • Cash +€238,028

    up €238,028 (+204%), from €116,732 to €354,760

    mainly Receivables within one year (+€195,905) and Net result for the year (+€169,553)

  • Receivables within one year -€195,905

    down €195,905 (-55.5%), from €353,066 to €157,161

    of which Other amounts receivable: -€188,686

  • Tangible fixed assets -€25,961

    down €25,961 (-13.7%), from €189,508 to €163,547

    of which Other tangible fixed assets: -€14,000

Equity and liabilities
  • Other debts +€86,652

    up €86,652 (+21.0%), from €412,259 to €498,911

  • Reserves -€55,900

    down €55,900 (-46.9%), from €119,274 to €63,374

Income statement
  • Gross operating margin -€10,415

    down €10,415 (-3.9%), from €268,011 to €257,596

  • Staff costs +€3,809

    up €3,809 (+16.0%), from €23,738 to €27,547

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €181,867
Gross operating margin -€10,415
Staff costs -€3,809
Depreciation -€41
Other operating charges -€513
Financial income +€200
Financial charges +€1,635
Taxes +€629
Result 2025 €169,553
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€463,481
Investment €0
Financing -€225,453
Cash 2024 €116,732
Net result for the year +€169,553
Depreciation +€25,961
Stocks and contracts -€5,550
Receivables within one year +€195,905
Deferred charges and accrued income -€1,280
Trade debts -€1,949
Tax, wage and social debts -€4,293
Other debts +€86,652
Accrued charges and deferred income -€1,520
Contributions, distributions and other -€225,453
Cash 2025 €354,760
brings cash intakes cash out
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €858,578 €881,569 +€22,991 +2.7%
Fixed assets 21/28 €192,008 €166,047 -€25,961 -13.5%
Tangible fixed assets 22/27 €189,508 €163,547 -€25,961 -13.7%
Plant, machinery and equipment 23 €87,469 €76,344 -€11,125 -12.7%
Furniture and vehicles 24 €3,623 €2,787 -€836 -23.1%
Other tangible fixed assets 26 €98,416 €84,416 -€14,000 -14.2%
Financial fixed assets 28 €2,500 €2,500 = 0.0%
Current assets 29/58 €666,569 €715,522 +€48,952 +7.3%
Stocks and contracts in progress 3 €196,080 €201,630 +€5,550 +2.8%
Stocks 30/36 €196,080 €201,630 +€5,550 +2.8%
Amounts receivable within one year 40/41 €353,066 €157,161 -€195,905 -55.5%
Trade receivables 40 €50,140 €42,920 -€7,220 -14.4%
Other amounts receivable 41 €302,926 €114,241 -€188,686 -62.3%
Cash at bank and in hand 54/58 €116,732 €354,760 +€238,028 +204%
Deferred charges and accrued income 490/1 €691 €1,970 +€1,280 +185%
Total equity and liabilities 10/49 €858,578 €881,569 +€22,991 +2.7%
Equity 10/15 €344,274 €288,374 -€55,900 -16.2%
Contributions 10/11 €225,000 €225,000 = 0.0%
Reserves 13 €119,274 €63,374 -€55,900 -46.9%
Distributable reserves 133 €119,274 €63,374 -€55,900 -46.9%
Amounts payable 17/49 €514,304 €593,195 +€78,891 +15.3%
Amounts payable within one year 42/48 €493,937 €574,348 +€80,411 +16.3%
Trade debts 44 €69,260 €67,311 -€1,949 -2.8%
Suppliers 440/4 €69,260 €67,311 -€1,949 -2.8%
Taxes, remuneration and social security 45 €12,418 €8,126 -€4,293 -34.6%
Taxes 450/3 €8,949 €3,937 -€5,012 -56.0%
Remuneration and social security 454/9 €3,470 €4,189 +€719 +20.7%
Other amounts payable 47/48 €412,259 €498,911 +€86,652 +21.0%
Accrued charges and deferred income 492/3 €20,367 €18,847 -€1,520 -7.5%
Remuneration, social security and pensions 62 €23,738 €27,547 +€3,809 +16.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €25,920 €25,961 +€41 +0.2%
Other operating charges 640/8 €3,630 €4,144 +€513 +14.1%
Gross operating margin 9900 €268,011 €257,596 -€10,415 -3.9%
Operating profit (loss) 9901 €214,722 €199,944 -€14,778 -6.9%
Financial income 75/76B €736 €937 +€200 +27.2%
Recurring financial income 75 €736 €937 +€200 +27.2%
Financial charges 65/66B €23,824 €22,189 -€1,635 -6.9%
Recurring financial charges 65 €23,824 €22,189 -€1,635 -6.9%
Profit (loss) for the period before taxes 9903 €191,634 €178,692 -€12,942 -6.8%
Income taxes 67/77 €9,767 €9,138 -€629 -6.4%
Profit (loss) for the period 9904 €181,867 €169,553 -€12,314 -6.8%
Profit (loss) for the period to be appropriated 9905 €181,867 €169,553 -€12,314 -6.8%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.